Trial · NCT03186209
Adverse events162
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 162
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Pyrexia | General disorders | Benralizumab 30 mg | 18 | 348 | 22 |
| other | Pyrexia | General disorders | Placebo | 9 | 347 | 9 |
| other | Bronchitis | Infections and infestations | Benralizumab 30 mg | 11 | 348 | 15 |
| other | Bronchitis | Infections and infestations | Placebo | 27 | 347 | 40 |
| other | COVID-19 | Infections and infestations | Benralizumab 30 mg | 11 | 348 | 11 |
| other | COVID-19 | Infections and infestations | Placebo | 6 | 347 | 6 |
| other | Nasopharyngitis | Infections and infestations | Benralizumab 30 mg | 28 | 348 | 36 |
| other | Nasopharyngitis | Infections and infestations | Placebo | 33 | 347 | 48 |
| other | Otitis media | Infections and infestations | Benralizumab 30 mg | 11 | 348 | 11 |
| other | Otitis media | Infections and infestations | Placebo | 8 | 347 | 9 |
| other | Pharyngitis | Infections and infestations | Benralizumab 30 mg | 13 | 348 | 13 |
| other | Pharyngitis | Infections and infestations | Placebo | 13 | 347 | 14 |
| other | Pneumonia | Infections and infestations | Benralizumab 30 mg | 9 | 348 | 13 |
| other | Pneumonia | Infections and infestations | Placebo | 16 | 347 | 19 |
| other | Rhinitis | Infections and infestations | Benralizumab 30 mg | 13 | 348 | 14 |
| other | Rhinitis | Infections and infestations | Placebo | 6 | 347 | 9 |
| other | Upper respiratory tract infection | Infections and infestations | Benralizumab 30 mg | 120 | 348 | 200 |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 120 | 347 | 230 |
| other | Urinary tract infection | Infections and infestations | Benralizumab 30 mg | 9 | 348 | 10 |
| other | Urinary tract infection | Infections and infestations | Placebo | 12 | 347 | 14 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03186209/events